TREC: Transforming Recovery Through Exercise and Community

Sponsor
Butler Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03065049
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
150
1
3
71
2.1

Study Details

Study Description

Brief Summary

The primary aim of this study is to develop a feasible, acceptable, and effective multilevel physical activity (PA) intervention that addresses both individual and interpersonal factors that can be easily scalable and delivered in the context of a methadone clinic. To do so, the investigators will train methadone maintenance treatment (MMT) patients who are already engaging in PA at public health recommended levels to deliver a group-based PA intervention to physically inactive MMT patients at a large community-based methadone clinic. Through the development of interpersonal relationships and social support, the investigators expect that MMT peers who have successfully navigated challenges associated with PA in this population (i.e. depression, smoking, triggers for drug use in environment) will help physically inactive MMT patients increase self-efficacy and motivation for initiating and sustaining PA.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Peer-Facilitated Counseling
  • Behavioral: Fitbit activity tracker
N/A

Detailed Description

Opioid Use Disorders (OUDs) are a highly prevalent and costly public health concern in the United States, with over 2.59 million Americans qualifying for abuse or dependence of opioids in 2015. Methadone maintenance treatment (MMT), involving daily distribution of methadone at regulated clinics, is the most common treatment for opioid use disorder. While MMT has been effective in helping OUD patients improve their quality of life, the overwhelming majority of these patients continue to engage in unhealthy lifestyles (e.g., physical inactivity and cigarette smoking) that lead to significant physical and mental health morbidities. For example, patients in MMT have much higher rates of cardiovascular disease, diabetes, hypertension, obesity, depression, sleep difficulties, and cognitive impairments than age-matched controls, which lead to premature death. Given the mental health, physical health, and drug use related benefits of physical activity (PA), interventions targeting increases in PA in patients receiving MMT could have a significant impact on reducing their overall morbidity and mortality.

To date, few PA studies have been conducted with substance abusing populations - and, only one small pilot study with MMT patients. The goal of this project is to develop a feasible, acceptable and effective multilevel PA intervention that addresses both individual and interpersonal factors that can be easily scalable and delivered in the context of a health care setting (i.e., methadone clinics). To do so, the investigators are proposing to train MMT patients who are already engaging in PA at public health recommended levels to deliver a group-based PA intervention to physically inactive MMT patients at SSTAR Lifeline, a large community-based methadone clinic in Fall River, Massachusetts. Peer-facilitated interventions for self-management skills are common in the care of patients with chronic medical conditions. Peers may play a particularly important role in increasing physical activity in MMT, as this population faces unique and significant barriers to PA (e.g., depression, smoking, minimal social supports). Through the development of interpersonal relationships, the investigators expect that MMT peers who have successfully navigated these challenges will help physically inactive MMT patients increase self-efficacy and motivation for initiating and sustaining PA.

The aims of the study include:
  1. PHASE 1 (Peer-PA Manual Development):
  • To develop a theoretically-informed peer-facilitated PA plus Fitbit (Peer-PA+Fitbit) intervention specific to SSTAR Lifeline, in order to help patients in MMT increase levels of physical activity.
  1. Focus groups will be conducted with: 1) MMT patients who are currently physically active and 2) MMT patients who are NOT meeting recommended PA levels to help inform intervention development.

  2. The investigators will: (1) develop a manualized Peer-PA intervention (that includes the use of a Fitbit activity monitor for self-monitoring PA and additional social networking), (2) create a training protocol for MMT patients to become peer-facilitators, and (3) identify safe, walkable paths in participant neighborhoods.

  3. PHASE 2 (Open Pilot):

  • An open pilot trial will be conducted with 20 MMT patients to determine the feasibility, acceptability, and short term increases in PA of the Peer-PA+Fitbit intervention. At the end of 3 months:
  1. Feedback will be obtained on Peer-PA+Fitbit from both the MMT peers and participants through self-report measures and qualitative interviews.

  2. Adherence to the intervention will be determined through group attendance and Fitbit data.

  3. Short-term increases in physical activity levels will be examined through objectively measured PA.

  4. PHASE 3 (Randomized Clinical Trial; RCT)

To conduct a 3-arm preliminary RCT of Peer-PA+Fitbit compared to Fitbit Only and compared to Usual Care (UC) among 150 MMT patients. We hypothesize that, Peer-PA+Fitbit will be superior to Fitbit Only and that Fitbit Only will be superior to UC on the following:

  1. Higher levels of short-term (3-month) and long-term (6- and 12-month) objectively-measured steps/day and moderate-to-vigorous physical activity (MVPA)

  2. Fewer days of drug use and lower levels of depression and anxiety symptoms at each follow-up

  3. Higher levels of theoretically-relevant, PA-related variables including: self-efficacy, internal motivation, and social support at 3- and 6-month follow-ups

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance
Actual Study Start Date :
Sep 30, 2016
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Peer-PA+Fitbit

Participants will engage in a 12-week physical activity intervention guided by a peer-facilitator at the methadone clinic they receive treatment. Participants will attend weekly groups, engage in a guided walking group, and utilize the Fitbit to self-monitor physical activity.

Behavioral: Peer-Facilitated Counseling
Participants will engage in a 12-week physical activity intervention guided by a peer-facilitator at the methadone clinic they receive treatment. Participants will attend weekly groups, engage in a guided walking group, and utilize the Fitbit to self-monitor physical activity.

Behavioral: Fitbit activity tracker
Participants will be given a Fitbit activity tracker to monitor physical activity.

Active Comparator: Fitbit Only

Participants will be given a Fitbit activity tracker along with brief advice for increasing physical activity.

Behavioral: Fitbit activity tracker
Participants will be given a Fitbit activity tracker to monitor physical activity.

No Intervention: Usual Care

Participants do not receive any intervention but participate in the assessments only.

Outcome Measures

Primary Outcome Measures

  1. Minutes of moderate-to-vigorous physical activity (MVPA)/week [12 month]

    Measured by accelerometry

Secondary Outcome Measures

  1. Acceptability of the Intervention assessed with the Client Satisfaction Questionnaire [12 weeks]

    Client Satisfaction Questionnaire (CSQ-8) Total score = summation of scores from each question Maximum score for each question is 4 points (range from 1 - 4) Maximum score for the measure is 32 The higher the total score, the better the acceptability

  2. level of depressive symptoms [12 month]

    Center for Epidemiological Studies Depression Scale (CES-D) Total score = summation of scores from each question Scoring: 0 = Rarely or None of the time (Less than 1 day), 1 = Some or a Little of the time (1-2 days), 2 = Occasionally or a Moderate Amount of time (3-4 days), 3 = Most or All of the time (5-7 days) Maximum score for the measure is 60 Higher scores = higher symptoms of depressive symptomatology

  3. level of anxiety symptoms [12 month]

    Generalized Anxiety Disorder 7-item scale (GAD-7) Total score = summation of scores from each question Scoring for items #1-7: 0 = Not at all, 1 = Several days, 2 = Over half the days, 3 = Nearly every day Item #8 is qualitative (not scored) and has the following answer choices: Not difficult at all, Somewhat difficult, Very difficult, Extremely difficult Maximum score for the measure is 21 Higher scores = higher anxiety severity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • receiving MMT at SSTAR and planning to remain in treatment for the next 6 months

  • low active (i.e., less than 90 minutes of MIPA per week for the past 6 months)

  • has access to a computer connected to the internet or a smartphone compatible with the Fitbit application

Exclusion Criteria:
  • a history of psychotic disorder or current psychotic symptoms

  • current suicidality or homicidality

  • marked organic impairment according to responses to the diagnostic assessments

  • physical or medical problems that would not allow safe participation in a program of moderate intensity physical activity (i.e., not medically cleared by methadone clinic physician)

  • current pregnancy or intent to become pregnant during the next 12 weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanley Street Treatment and Resources (SSTAR) Lifeline Fall River Massachusetts United States 02724

Sponsors and Collaborators

  • Butler Hospital
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Ana M Abrantes, Ph.D., Butler Hospital
  • Principal Investigator: Michael Stein, M.D., Boston University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Butler Hospital
ClinicalTrials.gov Identifier:
NCT03065049
Other Study ID Numbers:
  • 1609-001
  • 1R21DA041553-01A1
First Posted:
Feb 27, 2017
Last Update Posted:
Jun 2, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Butler Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2022